StriVectin still French favorite
This article was originally published in The Rose Sheet
Executive Summary
For the second time in less than a year, StriVectin-SD - the "stretch-mark cream turned anti-wrinkle phenomenon" - has been selected by French consumers as the No. 1 skin cream, according to a June 25 release. At the 17 annual "Grand Prix of Beauty," held in Paris by French beauty magazine Advantages, StriVectin-SD was named the favorite of 5,000 women across France - based on pleasure, innovation, confidence in the brand and effectiveness - "much to the chagrin of an audience comprised of French cosmetic giants the likes of Lancôme, ReVive, La Mer, L'Oréal, Yves Rocher and many others," Salt Lake City-based Klein-Becker says. Formerly, the cream was rated best by 264 women polled by France's leading consumer magazine, 60 Millions De Consommateur (1"The Rose Sheet" Oct. 16, 2006, In Brief)...
You may also be interested in...
StriVectin in France
Anti-wrinkle cream StriVectin-SD was rated the "best, most effective" anti-wrinkle face cream in a poll of 264 French women, according to France's leading consumer magazine, 60 Millions De Consommateur, Klein-Becker says. The women, who ranged in age from 30-70, chose StriVectin over 11 "famous formulations" by Dior,Chanel,ROC,L'Oréal, Lancôme and other high-end products, most of which are made in France, company says. Klein-Becker notes it was surprised by the results since French women are "extremely skeptical about products from America." StriVectin launched in Paris in August 2004 in the Sephora flagship store located on the Champs-Elysées...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.